RxDoctor Payments Data

Vasu Divi, MD

Otolaryngology/Facial Plastic Surgery · Stanford, CANPI 1750407334

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $40,307 of the $50,529 with a category attached, or 79.8%. 6 manufacturers reported payments, led by Regeneron at 56.5% of the total. 2025 is the largest year on record at $20,705, 8.2 times the $2,520 reported in 2019. Among otolaryngology/facial plastic surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$50,529in general payments, 2019–2025

Across 51 payments — averaging $990.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron$29K
  • Regeneron Healthcare Solutions, Inc.$20K
  • Johnson & Johnson$2K
  • Baxter Healthcare$268
  • Stryker$73
  • Springworks Therapeutics, Inc.$47
$1,500,048in research payments, 2019–2025

Across 178 payments — averaging $8427.23 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Regeneron$1.1M
  • Genentech, Inc.$368K
  • Merck$66K

What the payments were for

  • Consulting fees$40,30780%
  • Travel & lodging$8,51417%
  • Food & beverage$1,7073%

General payments by program year

19
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$50,529 in reported general payments places this provider in the 95th percentile of 102 otolaryngology/facial plastic surgery providers in California.

See all otolaryngology/facial plastic surgery providers in California

Medicare billing

Part B allowed, 2024
$217,182
Medicare patients
180
Services billed
519

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other otolaryngology/facial plastic surgery in Stanford

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →